Janus Venture Fund (JAVTX)

Moderate Small-Cap Growth Equities

SHARE CLASS

FUND FACTS (JAVTX)

Inception Date4/30/1985
NAV (As of 4/29/16)$60.11
Total Net Assets (As of 3/31/16)$2.58B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 0.92%
NET 0.92%

Performance (As of 3/31/16)
1 Year-8.84%
3 Year10.25%
5 Year10.33%
10 Year7.68%
Morningstar (As of 3/31/16)
CategorySmall Growth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

658 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/17.

Data as of 3/31/16. Index represents the Russell 2000® Growth Index.

TOP HOLDINGS (% of Fund)

SS&C Technologies Holdings Inc 2.23
Sally Beauty Holdings Inc 2.19
Broadridge Financial Solutions Inc 2.13
Euronet Worldwide Inc 2.07
Cadence Design Systems Inc 2.07
Sensient Technologies Corp 2.03
NICE-Systems Ltd (ADR) 1.88
ServiceMaster Global Holdings Inc 1.84
Blackbaud Inc 1.75
HEICO Corp 1.68
TOTAL19.87

CHARACTERISTICS

Number of Holdings
Equity Issues

113
Market Capitalization
Weighted Average
Median

$3.05B
$2.82B
Portfolio Turnover Ratio
(1-year trailing)

28.17%
Price/Earnings Ratio
(1-year forward)

22.93
Price/Book Ratio
(1-year forward)

4.36
Earnings Growth Rate
(1-year forward)

8.29%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
DCP Midstream Partners LP
WEX Inc
Tumi Holdings Inc
Euronet Worldwide Inc
ACADIA Pharmaceuticals Inc
DETRACTORS
Eagle Pharmaceuticals Inc/DE
j2 Global Inc
Diplomat Pharmacy Inc
Puma Biotechnology Inc
Aralez Pharmaceuticals Inc

SECTOR ALLOCATION (%)

FUND INDEX 
Information Technology 31.51 25.00
 
 
Health Care 19.95 24.82
 
 
Consumer Discretionary 14.76 17.68
 
 
Industrials 13.20 14.08
 
 
Financials 8.58 8.36
 
 
Consumer Staples 3.52 3.37
 
 
Materials 2.03 4.57
 
 
Energy 1.48 1.11
 
 
Cash & Equivalents 4.97 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 87.08 99.50
Non-U.S. Developed 7.95 0.18
Cash & Equivalents 4.97 -

REGIONS (%)

FUNDINDEX
North America 88.51 99.58
Europe 4.64 0.26
Africa/Mideast 1.88 0.09
Cash & Equivalents 4.97 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
$5 Billion to $10 Billion 17.13 -
$1 Billion to $5 Billion 66.18 -
$500 Million to $1 Billion 7.96 -
$250 Million to $500 Million 3.12 -
$100 Million to $250 Million 0.59 -
N/A 0.05 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.